APPLICATION
ANDA091044
TYPE
ANDA
ORIGINAL APPROVAL
2011-02-28
LATEST ACTION
2012-11-30
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
IMIQUIMODDiscontinued
IMIQUIMOD 5% · CREAM · TOPICAL
Approval history
2012-11-30Labeling · Supplement 3 · standardAP
2011-02-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.